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ABSTRACT
OBJECTIVE: To develop a model for evaluating the efficacy of drug-
dispensing service in primary health care.
METHODS: An efficacy criterion was adopted to determine the level 
of achievement of the service objectives. The evaluation model was 
developed on the basis of a literature search and discussions with experts. 
The applicability test of the model was conducted in 15 primary health care 
units in the city of Florianópolis, state of Santa Catarina, in 2010, and data 
were recorded in structured and pretested questionnaires.
RESULTS: The model developed was evaluated using five dimensions of 
analysis for analysis. The model was suitable for evaluating service efficacy 
and helped to identify the critical points of each service dimension.
CONCLUSIONS: Adaptations to the data collection technique may be 
required to adjust for the reality and needs of each situation. The evaluation 
of the drug-dispensing service should promote adequate access to medications 
supplied through the public health system.
DESCRIPTORS: Pharmaceutical Preparations, supply & distribution. 
Good Dispensing Practices. Primary Health Care. Health Services 
Evaluation.
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Drug therapy is the main therapeutic tool used for main-
taining health and treating disease processes in modern 
society. In this context, drug dispensing is an essential 
primary health care service provided by the Brazilian 
Unified Health System (SUS), and it comprises a 
set of services and actions known as pharmaceutical 
assistance. Pharmaceutical assistance aims to promote 
access and the rational use of medicines in the health 
care system. In this perspective, the efficacy of the drug-
dispensing service in primary health care units is closely 
associated with the efforts to implement pharmaceutical 
assistance. Through this service, beneficiaries will have 
their needs met with regard to access to medications, 
information, and guidance on drug therapy.a
However, access to medications in primary health care 
units remains limited.11 Only 45.0% of the beneficiaries 
who received a prescription through SUS had access 
to all the drugs prescribed.16 Since 1996, drug misuse 
is the leading cause of intoxicationb and the limited 
access to information and guidance on prescription 
drugs remains a reality.3
RESUMO
OBJETIVO: Elaborar modelo para avaliação da eficácia do serviço de 
dispensação de medicamentos na atenção básica à saúde. 
MÉTODOS: Foi adotado critério de eficácia para verificar o grau em que 
são alcançados os objetivos do serviço. O modelo de avaliação foi elaborado 
com base na literatura sobre o tema e na discussão com especialistas. O teste 
de aplicabilidade do modelo foi realizado em Florianópolis, SC, em 2010, 
em 15 unidades de saúde, com observação direta em formulário próprio para 
coleta de dados. 
RESULTADOS: O modelo apresentou-se adequado para avaliação da eficácia 
do serviço, elaborado com cinco dimensões de análise, permitindo identificar 
os pontos críticos de cada uma das dimensões do serviço. 
CONCLUSÕES: Adaptações à técnica de coleta de dados poderão ser 
necessárias para a realidade e necessidade de cada situação. A qualificação 
da dispensação deve propiciar o acesso qualificado aos medicamentos 
disponibilizados pela rede pública.
DESCRITORES: Preparações Farmacêuticas, provisão & distribuição. 
Boas Práticas de Dispensação. Atenção Primária à Saúde. Avaliação de 
Serviços de Saúde.
INTRODUCTION
Considering that the quality of drug therapy is directly 
related to the that of primary health care services3 and is 
strategical in the health care process involving pharmaco-
therapy, it is believed that the goals of the drug-dispensing 
service in primary health care are not being adequately met.
The aim of the present study was to develop a model for 
evaluating the efficacy of the drug-dispensing service 
in primary health care.
METHODS
This methodological14 and qualitative study aimed to 
develop a model for evaluating the management12 of the 
drug-dispensing service. We adopted the efficacy crite-
rion, which is defined as the evaluation of the extent to 
which the service goals and objectives are achieved in 
a group of beneficiaries in a given period, regardless 
of the costs involved.6
From this perspective, a literature review and discus-
sions with experts were conducted for the development 
a Agência Nacional de Vigilância Sanitária. Resolução da Diretoria Colegiada da ANVISA – RDC no 44, de 17 de agosto de 2009. Dispõe 
sobre Boas Práticas Farmacêuticas para o controle sanitário do funcionamento, da dispensação e da comercialização de produtos e da 
prestação de serviços farmacêuticos em farmácias e drogarias e dá outras providências. Diario Oficial Uniao. 18 ago 2009; Seção 1:78-81.
b Fundação Osvaldo Cruz. Sistema Nacional de Informações Tóxico-Farmacológicas. Brasil 2008: tabela 6: casos registrados de intoxicação 
humana por agente tóxico e circunstância [cited 2014 Apr 12]. Available from: http://www.fiocruz.br/sinitox/cgi/cgilua.exe/sys/start.
htm?sid=386 and/or http://www.fiocruz.br/sinitox_novo/media/Tabela%206%20-%202008.pdf
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of the evaluation model, which comprised a logical 
model, evaluation matrix (dimensions, indicators, 
measures, and parameters) and a classification model. 
A method known as “ideal type” was used for defining 
the parameters, and it allowed comparisons between 
the reality observed and a predetermined imaginary 
model, which needs to be consistent with this reality.c 
In addition, the developed model was tested. The data 
were obtained using the technique of direct observa-
tion of drug-dispensing services as well as a structured 
and pretested questionnaire-based interview in two 
municipal primary health care units. The data were 
standardized in a spreadsheet, and they were analyzed 
and classified according to the parameters established 
in the proposed evaluation model.
For the literature review, the Scientific Electronic 
Library Online (SciELO) was searched using the 
terms “drug dispensing” and “pharmaceutical assis-
tance”, without restriction on the publication date, study 
location, and/or language. For the second term, only 
assessment studies were considered. The search was 
performed in June 2009 and updated in March 2014.
The discussions with experts, with the aim of strength-
ening the internal validity of the study, were conducted 
in four specific periods during model development in 
the institutions where the research team worked. A total 
of 16 professionals were consulted and they included 
pharmacists from the municipal primary health care 
units where the model was tested, researchers involved 
in health care evaluation and in pharmaceutical sciences, 
and SUS managers from the state and municipality.
The tests were conducted in Florianópolis, SC, Southern 
Brazil, in 2010, using a study sample that was defined 
on the basis of the following factors: number of health 
districts present in the municipality, types of primary 
health care units, and the flow of beneficiaries, with 
the latter being defined as the mean number of people 
served daily by the pharmacies of each unit. Overall, 
15 primary health care units were selected, three in each 
of the five health districts in the municipality, so that one 
primary health care unit had pharmacies that were loca-
tions for the dispensing of drugs under special control 
via Ordinance MS 344/98d in the district and two units 
had pharmacies that did not have these special drugs. 
Among the two units not having the special drugs, one 
had a larger flow and the other had a smaller flow of 
beneficiaries in their respective pharmacies. In each 
unit selected, 10 services were recorded for each shift 
(morning and afternoon).
The main study limitation was considered to be the 
Hawthorne effect, a phenomenon whereby the subjects 
under observation may act differently when they are 
aware of being observed.8 Therefore, standard clarifi-
cation procedures were adopted to minimize this effect.
The study was approved by the Human Research Ethics 
Committee of the Universidade Federal de Santa 
Catarina (Opinion 541, 2009 December), as established 
by Resolution 196 of the National Health Council. In 
addition, research permission was obtained from the 
Municipal Health Secretariat of Florianópolis.
RESULTS
Evaluation model developed
For model building in 2009, among the studies 
reviewed, five were considered to be directly related 
to the goal of this study: two were conceptual studies 
discussing drug dispensing1,9 and three studies proposed 
drug-dispensing indicators to rate pharmaceutical assis-
tance.4,13,17 Considering the few nationwide studies 
found, two official publications10,e and two publica-
tions recognized in the research fieldf,g were included.
In 2014, considering the updated bibliography used to 
support the discussion of the results of the present study, 
three other studies on drug dispensing2,7,15 and two offi-
cial publicationsa,h were reviewed. One of these studies,7 
which was published after completion of the evalua-
tion model presented herein, was the only study that 
proposed a model for evaluating the drug dispensing.
By consulting other publications1,4,9,10,13,17,e,f,g and 
discussing with experts, the topic to be evaluated was 
defined as follows: drug dispensing is a health service 
that guides the beneficiary to make adequate use of 
medications, adhere to treatment, and prevent disease. 
The service should supply good-quality medicines, 
in the dose and concentration necessary for the treat-
ment prescribed, and with the required packaging for 
preserving product quality. Furthermore, the relation-
ship between the pharmacist and beneficiary should 
allow the identification and resolution of certain prob-
lems related to drug therapy and potential negative 
outcomes of the therapy in progress. For this purpose, 
c Tobar F, Yalour MR. Como fazer teses em saúde pública. Rio de Janeiro: FIOCRUZ; 2001.
d Ministério da Saúde, Secretaria de Vigilância em Saúde. Portaria nº 344, de 12 de maio de 1998. Aprova o Regulamento Técnico sobre 
substâncias e medicamentos sujeitos a controle especial. Diario Oficial Uniao. 31 dez 1998; Seção 1.
e Ministério da Saúde, Secretaria de Políticas de Saúde, Departamento de Atenção Básica. Assistência farmacêutica na atenção básica: 
instruções técnicas para sua organização. Brasília (DF); 2001.
f Dupim JAA. Assistência Farmacêutica: um modelo de organização. Belo Horizonte: SEGRAC; 1999.
g Perini E. Assistência Farmacêutica: fundamentos teóricos e conceituais. In: Acúrcio FA, organizador. Medicamentos e assistência 
farmacêutica. Belo Horizonte: COOPMED; 2003. p. 9-30.
h Ministério da Saúde, Secretaria de Ciência, Tecnologia e Insumos Estratégicos, Departamento de Assistência Farmacêutica e Insumos Estratégicos. 
Diretrizes para estruturação de farmácias no âmbito do Sistema Único de Saúde. Brasília (DF); 2009. (Série A. Normas e Manuais Técnicos).
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several activities are required, including technical 
actions, such as separation and preparation of the 
required medications as well as administrative proce-
dures related to inventory record and control, and clin-
ical actions, including the evaluation of prescription 
adequacy and guidance provided.
Considering the efficacy criterion, the following goals 
for drug dispensing were adopted: a) understanding the 
needs of beneficiaries or their guardians; b) evaluation 
of prescription adequacy; c) provision of good-quality 
medicines in the amount needed for effective treatment; 
d) provision of the necessary information to beneficiaries 
or their guardians; e) implementation of the systems for 
inventory control and beneficiary monitoring.
The Figure represents the logical model to evaluate the 
efficacy of drug-dispensing service; this model served 
as the reference when defining the indicators and used 
the following five dimensions of analysis that define 
the service dynamics: user embracement, evaluation 
of prescription, separation and preparation of medi-
cines, beneficiary guidance upon medicines delivery, 
and data recording.
The beneficiary approach served as indicator of the 
dimension user embracement. Primary health care units 
which attempt to understand beneficiaries’ needs aim 
to establish interpersonal relationships on the basis of 
trust and respect so as to address problems faced by the 
beneficiaries.9,f Therefore, it was important to verify 
whether the service provided could identify service 
beneficiaries and whether professionals were avail-
able to give support on relevant issues related to drug 
therapy or those associated with health care throughout 
the drug-dispensing process.
The dimension “evaluation of prescription” used two 
indicators: analysis of prescription and evaluation 
of drug therapy. The drug prescription to a benefi-
ciary, either to initiate or continue treatment, should 
be analyzed and interpreted according to its legal and 
technical aspects (drug name, dosage, dosage form, 
and frequency and duration of treatment) before 
preparing the medications or authorizing their distri-
bution, ensuring that they are free from problems that 
may bring losses.f To this end, it was observed that the 
service could identify any legal or technical noncon-
formity in the prescriptions. Moreover, the therapeutic 
aspect should be analyzed by investigating whether 
the therapies prescribed complied with basic param-
eters related to drug indication, dosage, contraindica-
tions, and interactions, and whether positive or nega-
tive outcomes occur during drug therapy, assuming the 
professionals’ responsibility for the therapies indicated. 
Although drug dispensing has important limitations in 
the identification and solution of problems related to 
drug therapy and the negative outcomes of drug therapy, 
this service can help solve some problems in this scope 
and/or guide beneficiaries towards a reassessment of 
drug therapy integrated with the reference health team.9 
Therefore, it was noted if there was identification of 
therapeutic inconsistencies and checking the health 
status of beneficiaries with the use of medicines.
The dimension “separation and preparation of medi-
cines” included two indicators: assessment of the 
quantitative and qualitative aspects of medicines, and 
compliance with the preparation techniques. The verifi-
cation of product quantity and expiration date before its 
distribution avoids qualitative and quantitative errors, 
which can compromise the effectiveness and safety 
 U
se
r 
em
br
ac
em
en
t
A
dd
re
ss
 th
e 
be
ne
fic
ia
ry
 o
r 
gu
ar
di
an
 to
un
de
rs
ta
nd
 th
ei
r 
ne
ed
s.
Evaluation of prescription
Evaluate the adequacy of prescription via the evaluation
of prescription and drug therapy.
Separation and preparation of medicines
Provide quality medicines in the amount necessary for the treatment,
verifying their quantity and quality, and adopting
proper preparation techniques.
Beneficiary guidance upon medicines delivery
Provide necessary information to the beneficiaries or guardians,
and guide them on the dispensing process and the outcomes of drug therapy.
Data recording
Implement the inventory control system and beneficiary monitoring system,
recording product outflow/supply and the health care provided.
D
is
pe
ns
in
g 
w
as
 p
er
fo
rm
ed
Figure. Logical model for evaluating the efficacy of the drug-dispensing service in primary health care.
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of treatment.9,10,a,f Therefore, was observed if there 
was any inconsistency identification of the validity or 
quantity before delivering the medicine. After sepa-
rating the medications, the service should be provided 
in such a way that beneficiaries could maintain drugs in 
proper storage conditions and adequately identify them. 
Considering that some drugs purchased via municipal 
health system were those in the hospital stocks, their 
supply in the original packaging was often unfeasible; 
therefore, their fractionation was necessary. Thus, it 
was necessary to verify whether repackaging preserved 
product labeling, identification, and expiration date.
The dimension “beneficiary guidance upon medi-
cines delivery” employed two indicators: guidance on 
medicines use and guidance on the outcomes of drug 
therapy. Some data should not be omitted in this step, 
such as how much, when, and how to take these medi-
cations as well as treatment duration. At the initiation 
of treatment and during its duration, it is important to 
prioritize these aspects.9,10,a,f Therefore, it was neces-
sary to assess the provision of guidance on product use 
and on access to medications that were unavailable. 
Furthermore, it was necessary to verify whether bene-
ficiaries acknowledged the goal of treatment because 
those aware of the therapeutic effect to be achieved can 
better evaluate drug effectiveness and safety by diag-
nosing signs and symptoms that may indicate the need 
to return to primary health care services.9 Therefore, 
proper guidance on the purpose, safety, and effective-
ness of treatment was also investigated.
The dimension “data recording” used the indicators 
record of medicines outflow/supply and record of care 
rendered to the beneficiary. To meet the technical and 
administrative needs of inventory control, it is neces-
sary to record the outflow of dispensed medications. 
This helps to maintain the drug stocks needed to meet 
the demand, thereby avoiding inventory overlaps or 
product shortages.10 Accordingly, we assessed whether 
all drug outflow had been recorded in the inventory 
control system. In addition to this record, it is essential 
to register the service provided to the user for keeping 
the medical history of the beneficiary. The drugs 
provided, the amount dispensed, and any nonconfor-
mities and interventions during the drug-dispensing 
service must be recorded in the medical history of each 
beneficiary. The data recorded in the medical history 
helps to avoid prescription reuse and serves as a data 
source for other health care services and for the bene-
ficiaries themselves. The interventions recorded in the 
medical history are primarily those related to prescrip-
tion changes or interventions performed after benefi-
ciary’s complaints on therapy effectiveness or safety.9,10 
Accordingly, we verified whether inconsistencies, inter-
ventions, and drug therapy data had been recorded in 
the medical history of beneficiaries.
Table 1 summarizes the information in the question-
naire of an evaluation matrix, which consisted of 
dimensions, indicators, measures, and the parameters 
adopted in the model.
After data collection and analysis according to the 
parameters shown in Table 1, service efficacy in each 
primary health care unit was rated using the combina-
tion of attributes assigned to the five drug-dispensing 
dimensions according to the following guidelines:
• an acceptable drug-dispensing service cannot have 
unacceptable ratings in any of the dimensions of analy-
sis and should necessarily have acceptable ratings 
in the dimensions “evaluation of prescription” and 
“beneficiary guidance upon medicines delivery”;
• a regular service cannot have unacceptable ratings 
in the dimension “evaluation of prescription” and 
“beneficiary guidance upon medicines delivery”.
The attributes of the dimensions “evaluation of 
prescription” and “beneficiary guidance upon medi-
cines delivery” were considered to be more suitable in 
the final rating of the service because these dimensions 
required specific cognitive conditions – clinical exper-
tise – for service provision. The dimension “separation 
and preparation of medicines”, despite being a specific 
activity of the drug-dispensing service, required less 
complex cognitive conditions compared with those of 
the previous two dimensions. The dimensions “user 
embracement” and “data recording”, although impor-
tant, were not exclusive of the drug-dispensing service 
and were part of all primary health care practices.
Therefore, the efficacy of the drug-dispensing service in 
the primary health care units could be classified as follows:
• acceptable service: most of its dimensions are classi-
fied as good. Dimensions “evaluation of prescription” 
and “beneficiary guidance upon medicines delivery” 
should necessarily be considered acceptable, and 
no dimensions should be considered unacceptable;
• regular service: up to two dimensions are classified 
as unacceptable, except for the dimensions “eva-
luation of prescription” and “beneficiary guidance 
upon medicines delivery”;
• unacceptable service: most of its dimensions are 
rated as unacceptable, or the dimensions “evalu-
ation of prescription” and “beneficiary guidance 
upon medicines delivery” are rated as unacceptable.
The following rating was defined for the municipality:
• acceptable: most of its services are acceptable and 
up to 20.0% services are classified as unacceptable;
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• unacceptable: > 40.0% municipal services are 
unacceptable;
• regular: includes other cases.
Table 2 summarizes the logic of classification of the 
proposed model.
Testing the evaluation model
In the 15 primary health care units evaluated, 
288 services were provided; 12 services from two 
primary health care units were not included because of 
the decreased flow of beneficiaries. There was a limi-
tation to measure the indicators analysis of prescrip-
tion and assessment of the quantitative and qualitative 
aspects of medicines because these indicators can only 
be observed if happen verbal manifestation between 
health worker and beneficiary during drug-dispensing 
service. However, all the services provided identified 
cases of legal or technical nonconformities on prescrip-
tions. Most of these cases were related to the expiration 
date of prescription, which is regulated by the munici-
pality, and product usage, which led professionals to 
discuss this issue with the beneficiary. Thus, relevant 
data for the indicator analysis of prescriptions were 
easily obtained. The indicator assessment of the quan-
titative and qualitative aspects of medicines could not 
be fully rated because only the quantitative aspects 
were witnessed. According to the reports of those who 
participated in the study, to make drug dispensing more 
agile, the quality and validity of medicines are assessed 
in other sectors of the pharmaceutical services, such as 
product storage and inventory control.
Table 2. Classification model of the degree of efficacy of drug dispensing in municipal primary health care units.
Dimension Indicator and measure
Rating of variable 
efficacy
Rating of service efficacy
Rating of 
municipality efficacy
User 
embracement
Beneficiary approach
Was a friendly approach 
adopted?
Yes = Acceptable
No = Unacceptable
ACCEPTABLE
Predominance of acceptable 
ratings, presence of 
acceptable rating in the 
dimensions “evaluation 
of prescription”, and 
“beneficiary guidance 
upon medicines 
delivery”, and absence of 
unacceptable ratings
REGULAR
Maximum of two 
unacceptable ratings and 
absence of unacceptable 
ratings in the dimensions 
“evaluation of prescription” 
and “beneficiary guidance 
upon medicines delivery”
UNACCEPTABLE
Predominance of 
unacceptable ratings or
presence of unacceptable 
ratings in the dimensions 
“evaluation of prescription” 
and “beneficiary guidance 
upon medicines delivery”
ACCEPTABLE
Predominance of 
acceptable ratings;
≤ 20.0% of 
unacceptable ratings
REGULAR
≤ 40.0% of 
unacceptable ratings
UNACCEPTABLE
> 40.0% of 
unacceptable ratings
Evaluation of 
prescription
Analysis of prescription
Was the analysis of 
prescription performed?
Yes + Yes = Acceptable
Yes + No = Regular
No + No = 
Unacceptable
Evaluation of drug therapy
Was the evaluation of 
drug therapy performed?
Separation and 
preparation of 
medicines
Assessment of the quantity 
and quality of medicines
Was the verification 
of drug quantity 
and expiration date 
performed?
Yes + Yes = 
Acceptable
Yes + No = Regular
No + No = 
Unacceptable
Compliance with the 
preparation techniques
Were the medications 
prepared?
Beneficiary 
guidance upon 
medicines 
delivery
Guidance on medicines use
Was any guidance of 
medication use provided?
Yes + Yes = 
Acceptable
Yes + No = Regular
No + No = 
UnacceptableGuidance on the 
outcomes of drug therapy
Was any guidance on the 
results of drug therapy 
provided?
Data recording Record of medicines 
outflow/supply
Was product outflow/
supply recorded?
Yes + Yes = Acceptable
Yes + No = Regular
No + No = 
Unacceptable
 Record of care rendered 
to the beneficiary
Was the care provided to 
the beneficiary recorded?
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DISCUSSION
The proposed evaluation model expanded the under-
standing of drug dispensing compared with the model 
used by Escher et al7 because it incorporated elements 
of pharmaceutical care adopted by Angonesi1,2 and 
Galato et al,9 among other authors. This may explain 
the small but significant difference between Escher et 
al’s model and our model.
Furthermore, the proposed model allowed the measure-
ment of service efficacy. Given that an efficacy service, 
when achieving its goals and objectives, is more likely 
to produce the expected results compared with an inef-
ficacy service, the selection of this criterion allowed us 
to focus on the work process. Its mode of classification, 
in which the sum of the scores and combination of the 
results could assess the efficacy of each dimension, 
for each service and municipality or a set of studied 
services, allowed the identification of critical points 
that deserve intervention, both at the primary health 
care unit and municipal levels. The model proved to 
be feasible for different types of primary health care 
units/pharmacies in each municipality.
Our collected data provided the necessary information 
to measure the indicators, and the collection method 
adopted can be adapted to the reality and needs of each 
municipality, minimizing the limitations inherent to the 
technique of direct observation. A previous study exam-
ined different data collection methods for the evalua-
tion of drug dispensing in pharmacies and indicated that 
the best option is the one adopted by external observers 
and simulated clients aimed to enhance the internal and 
external validity of the study.5
With regard to the limitation inherent to the direct obser-
vation technique, we tried to minimize the Hawthorne 
effect on the health worker by explaining to each partic-
ipant, upon signing the consent form, that the aim was 
to evaluate the service, primary health care units, and 
municipal system, and not themselves, and that their 
confidentiality would be maintained, including the 
confidentiality of the primary health care units studied. 
It is likely that this effect may have influenced the 
degree of efficacy, which was perceived in the indi-
cator record of medicines outflow/supply, for which it 
was observed that all drug-dispensing services provided 
maintained an outflow record of all drug prescriptions 
provided, which is not common in these services. 
Concerning the Hawthorne effect on the beneficiaries, 
this technique served for the researcher to act as an aide 
of the health worker. 
For a better understanding of the parameters evaluated, 
fourth-generation evaluation studies are recommended, 
in which the subjects involved in the service should be 
considered during the entire evaluation process.
Despite its poor scientific evaluation in Brazil, drug 
dispensing has been available to the public for years 
as the main source of access to prescription drugs. In 
addition to the few studies on drug dispensing, their 
publishing and indexing in national databases are scarce. 
However, the studies available have raised concerns 
about the quality of drug-dispensing services in Brazil.
This scenario, coupled with the conceptual diversity 
and broad understanding of the dimensions involved 
in drug dispensing and the untapped potential of this 
service in support of outpatient follow-up, raises 
concerns regarding the concept of drug dispensing and 
the pharmaceutical assistance services that SUS has 
been implementing.
A constant service evaluation model is necessary so 
that SUS can implement its principles and guidelines. 
To further the importance of this issue, we hope that 
this study will contribute to the evaluation of drug-
dispensing services under SUS and the institutional-
ization of evaluations to improve the decision-making 
process in which the democratic principle is respected 
and the political directionality for transformation of 
reality is achieved.
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Limitations to the access to medication in basic health care services still exist and they need to be addressed. These 
include the inability of many users to obtain all prescription medications, the inadequate use of medications (a public 
health problem), and the limited access to information and guidance regarding the use of these medications.
The aim of this study was to present an evaluation model to assess the effectiveness and management of drug 
distribution service in primary health care. Its results are expected to provide information that helps promote deci-
sion making with the view to ensure the quality of this service through Brazilian Unified Health System (SUS). 
The proposed evaluation model is based on the adoption of an efficacy criterion and allows the assessment of the 
level of achievement of the service objectives. An effective drug distribution service is more likely to produce the 
expected results. The efficacy criterion allowed us to focus on the operational processes. This evaluation model 
allowed the evaluation of the efficacy of each distribution variable (acceptance, evaluation of prescription; medi-
cation sorting and preparation, guidance, and recording of the data generated) for each service and city evaluated, 
with the goal to identify the critical points that need intervention, both at the level of the health care units/phar-
macies and at the municipal level. 
With the implementation of proposed evaluation model, the results are expected to help SUS managers to take 
concrete political decisions that could improve the drug distribution system within the primary health care network.
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